Aptamer Technology Platform We develop aptamers (short, synthetic DNA- or RNA-based molecules) under strict laboratory conditions using our automated high-throughput selection platform. Aptamers have flexible, sequence-specific structures that…

4th October 2019 Isolating a single target from a complex sample can be challenging and is often a multi step process which requires increased specificity for the target….